ADAP Advocacy has launched a national advocacy campaign calling for reforms to the 340B Drug Pricing Program, highlighting declining charity care among eligible hospitals that disproportionately impacts minority communities. The campaign questions whether the program has become "too big to fail" as hospitals appear to be retaining savings rather than expanding services for low-income patients.
Brandon M. Macsata, CEO of ADAP Advocacy, explained that the 340B Program was designed to enable hospitals to provide free care and financial assistance to poor patients through discounted medications from manufacturers. "Drug manufacturers offer medications to hospitals at reduced rates so that they, in turn, can serve more low-income patients—but that isn't happening because these hospital systems are pocketing the money," Macsata stated. Recent data shows that 69% of 340B disproportionate share hospitals offer charity care at rates below the national average.
The "340B Too Big To Fail" campaign, which will run through the end of the year, focuses on multiple concerning trends including declining charity care, rising healthcare executive compensation, and increasing patient medical debt. ADAP Advocacy has developed an interactive map to visualize these issues across hospital systems. The commercial supporting the campaign is available online at https://youtu.be/7uqGTHT7Zx4.
For business and technology leaders in healthcare, this campaign highlights significant accountability questions about how financial benefits from federal programs are being utilized. The disconnect between program intent and actual outcomes suggests potential systemic failures in oversight mechanisms. The focus on executive compensation alongside declining charity care raises ethical considerations about resource allocation within healthcare organizations.
The implications extend beyond individual hospitals to affect pharmaceutical manufacturers participating in the 340B program, policymakers considering program reforms, and patients relying on these safety-net services. As healthcare costs continue to rise nationally, the efficient use of program savings becomes increasingly critical for maintaining accessible care. The campaign's timing coincides with broader discussions about healthcare affordability and equity, making its findings particularly relevant for stakeholders across the industry.
ADAP Advocacy's work focuses on promoting and enhancing AIDS Drug Assistance Programs and improving access to care for persons living with HIV/AIDS. The organization collaborates with advocates, community organizations, healthcare providers, government agencies, patients, pharmaceutical companies, and other stakeholders to raise awareness and foster greater community collaboration around these critical issues.
